Growth and PTH in prepubertal children on long-term dialysis

Janette Cansick1, Simon Waller, Deborah Ridout

  • 1Department of Nephrology, Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1N 3JH, UK. jcansick@doctors.org.uk

Insights

Growth failure in children on dialysis is common, but maintaining good nutrition and phosphorus control can prevent further height loss. Younger children (<2 years) may experience catch-up growth during their first year of dialysis.

Area of Science:

  • Pediatric Nephrology
  • Growth and Development
  • Renal Osteodystrophy

Background:

  • Growth failure is a significant complication for pediatric patients undergoing dialysis.
  • Renal bone disease is a potential contributing factor to impaired growth in these children.
  • Understanding growth patterns and influencing factors is crucial for managing children on dialysis.

Purpose of the Study:

  • To analyze growth patterns in children on dialysis.
  • To investigate the relationship between parathyroid hormone (PTH), calcium, and phosphate levels and growth in pediatric dialysis patients.
  • To identify strategies for optimizing growth in children with kidney disease.

Main Methods:

  • Retrospective review of case notes for 35 children on dialysis.
  • Data collected included age, dialysis duration, height standard deviation score (HtSDS), PTH, calcium, and phosphate levels.
  • Follow-up data collected until age 10 years, growth hormone initiation, or renal transplantation.

Main Results:

  • The mean HtSDS at the start of dialysis was -2.06; no significant change in HtSDS per year was observed overall.
  • Children under 2 years old showed catch-up growth in their first year on dialysis (median HtSDS change of 0.31).
  • PTH levels were elevated (median 1.52 times the upper limit of normal) but did not correlate with growth; calcium and phosphate levels were within or slightly above normal ranges.

Conclusions:

  • Intensive nutritional therapy and phosphorus control are vital to maintain PTH levels within the normal range and prevent further height loss in children on dialysis.
  • Early intervention and management, particularly in younger children (<2 years), may facilitate catch-up growth during the initial year of dialysis.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
5.2K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679